CLChao Lv

Chao Lv

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chao Lv has a total of 32 co-authors. Here are the top co-authors by number of shared publications:

  • Yu Tian

    Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, China

    8 shared publications
  • Chuhan Ma

    Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, P. R. China

    5 shared publications
  • Huixin Hu

    Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, P. R. China

    4 shared publications
  • Chongli Zhong

    Department of Interventional Radiology, Shengjing Hospital of China Medical University, Shenyang, China

    3 shared publications
  • Yang Li

    Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, P. R. China

    3 shared publications
  • Bing Han

    Department of Gastroenterology, First Affiliated Hospital of China Medical University, Shenyang, China

    2 shared publications

Latest Publications

  • Open Access

    Correction: The B7 family subgroup reflects tumor cell heterogeneity and patient post-operative prognosis in gallbladder cancer

    by Chuhan Ma, Huixin Hu, Yang Li, Chongli Zhong, YunHao Dong, Zhanhao Chang, Shuo Xu, Yuyang Zhang, Hangqi Hu, Chao Lv, et al.

  • Cross-Dataset UNet: A UNet Method with Cross-Dataset Aware Module for Multi-center Medical Image Segmentation

    by Meng Wang, Jianhua Ren, Yongwei Tang, Yarong Feng, Yuxin Liang, Chao Lv

  • Open Access

    The B7 family subgroup reflects tumor cell heterogeneity and patient post-operative prognosis in gallbladder cancer

    by Chuhan Ma, Huixin Hu, Yang Li, Chongli Zhong, YunHao Dong, Zhanhao Chang, Shuo Xu, Yuyang Zhang, Hangqi Hu, Chao Lv, et al.

    To elucidate the biological heterogeneity of gallbladder cancer (GBC) cells and refine post-operative risk stratification by investigating the expression a


  • Open Access

    Spatiotemporal dynamics of tumor-associated neutrophils: bridging the gap between cancer progression and immunotherapy

    by Xiangyuan Chu, Junying Ma, Shihua Li, Meng Wang, Yu Tian, Chao Lv

    Neutrophils, traditionally regarded as short-lived first responders of innate immunity, have emerged as pivotal regulators within the tumor microenvironment (TME). Recent advances reveal that tumor-associated neutrophils (TANs) and neutrophil extracellular traps (NETs) exhibit remarkable spatiotemporal heterogeneity, with their phenotypes and functions dynamically evolving across tumor developmental stages and anatomical niches. TANs and NETs display dual and context-dependent roles: they can promote tumor progression via immune suppression, angiogenesis, extracellular matrix remodeling, and metastatic niche formation, yet also exert anti-tumor functions through cytotoxicity and antigen presentation under specific microenvironmental cues. This review systematically dissects the spatial and temporal dynamics of TANs and NETs, emphasizing their molecular regulation by tumor-derived secretomes, chemokine gradients, hypoxia, stromal interactions, and inflammatory signaling networks. We further delineate the bidirectional crosstalk between TANs and other immune or stromal components that contributes to immune evasion and therapy resistance. Beyond mechanistic insights, we highlight emerging therapeutic strategies, ranging from chemokine axis blockade and phenotypic reprogramming to NETs inhibition and clearance, that hold promise for disrupting neutrophil-mediated tumor support. Finally, we advocate for the integration of cutting-edge spatial and single-cell multi-omics, imaging cytometry, and AI-assisted spatial modeling to enable high-resolution mapping of neutrophil dynamics in situ and to guide precision immunotherapy.


  • Open Access

    Multi-modal integration of histopathology and transcriptomics reveals STAB1+ macrophage-associated efferocytosis as a suppressive immune mechanism in colon adenocarcinoma

    by Zhanhao Chang, Chongli Zhong, Shuo Xu, Yuyang Zhang, Xingqi Guo, Jielin Yu, Zitong Xu, Shukun Han, Bing Han, Chao Lv, et al.

    Colon adenocarcinoma (COAD) has a limited response to immunotherapy due to its immunologically “cold” tumor microenvironment (TME). Efferocytos


  • Open Access

    Extracellular matrix remodeling fibroblasts govern the tumor microenvironment disparity between adenomatous lesions and adenocarcinoma in gallbladder

    by Chuhan Ma, Huixin Hu, Hanrong Li, Bing Han, Chao Lv, Yu Tian

    Introduction: Gallbladder cancer (GBC) is a highly lethal cancer with a poor prognosis. The adenoma-carcinoma sequence is a recognized model for GBC development, but its underlying mechanisms are not well understood. Methods: Human specimens were collected from Shengjing Hospital of China Medical University. Single-cell isolation and sequencing were conducted on cells from four GBC and four gallbladder adenomatous lesions (GBA) samples, and the raw gene expression matrices were analyzed using R software with the Seurat package. This included cell type annotation, differential gene expression analysis, functional enrichment, and gene set score calculation. Additional analyses such as protein-protein interaction network, immune infiltrate analysis, high-dimensional weighted gene co-expression network analysis, and cell-cell communication analysis were also performed. Results: The study revealed that epithelial-mesenchymal transition (EMT) plays a key role in the malignant transformation of epithelial cells from GBA to GBC. The immune landscape of GBC is predominantly immunosuppressive compared to the inflammatory environment within GBA. A specific subset of fibroblasts with extracellular matrix remodeling capabilities appears to be a major driver of the TME differences between GBC and GBA, potentially acting through COL1A2-mediated cell communication. Discussion: This work highlights the distinct roles of various cell types in the TME of GBA and GBC, and emphasizes the importance of understanding the mechanisms of malignant transformation from adenomatous lesion to carcinoma in the gallbladder. The findings pave the way for further research into the mechanisms underlying the adenoma-carcinoma sequence.


  • Open Access

    Lipotoxicity, lipid peroxidation and ferroptosis: a dilemma in cancer therapy

    by Chuhan Ma, Huixin Hu, Hao Liu, Chongli Zhong, Baokang Wu, Chao Lv, Yu Tian

    The vulnerability of tumor cells to lipid peroxidation, driven by redox imbalance and lipid overabundance within the tumor microenvironment (TME), has become a focal point for novel antitumor strategies. Ferroptosis, a form of regulated cell death predicated on lipid peroxidation, is emerging as a promising approach. Beyond their role in directly eliminating tumor cells, lipid peroxidation and its products, such as 4-hydroxynonenal (HNE), exert an additional influence by damaging DNA and shaping an environment conducive to tumor growth and metastasis. This process polarizes macrophages towards a pro-inflammatory phenotype, dampens the antigen-presenting capacity of dendritic cells (DCs), and undermines the cytotoxic functions of T and NK cells. Furthermore, it transforms neutrophils into pro-tumorigenic polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs). The lipid peroxidation of stroma cells also contributes to tumor progression. Although advanced nanotherapies have shown the ability to target tumor cells precisely, they often overlook the nuanced effects of lipid peroxidation products. In this review, we highlight a synergistic mechanism in which lipid peroxidation products and ferroptosis contribute to an immunosuppressive state that is temporally distinct from cell death. This insight broadens our understanding of ferroptosis-derived immunosuppression, encompassing all types of immune cells within the TME. This review aims to catalyze further research in this underexplored area, emphasizing the potential of lipid peroxidation products to hinder the clinical translation of ferroptosis-based therapies. Graphical abstract


  • Open Access

    Targeting immune checkpoints on myeloid cells: current status and future directions

    by Chuhan Ma, Yang Li, Min Li, Chao Lv, Yu Tian

    Myeloid cells accumulate extensively in most tumors and play a critical role in immunosuppression of the tumor microenvironment (TME). Like T cells, myeloid cells also express immune checkpoint molecules, which induce the immunosuppressive phenotype of these cells. In this review, we summarize the tumor-promoting function and immune checkpoint expression of four types of myeloid cells: macrophages, neutrophils, dendritic cells, and myeloid-derived suppressor cells, which are the main components of the TME. By summarizing the research status of myeloid checkpoints, we propose that blocking immune checkpoints on myeloid cells might be an effective strategy to reverse the immunosuppressive status of the TME. Moreover, combining nanotechnology, cellular therapy, and bispecific antibodies to achieve precise targeting of myeloid immune checkpoints can help to avoid the adverse effects of systemic administration, ultimately achieving a balance between efficacy and safety in cancer therapy. Graphical abstract


  • Top Cited Papers
    Open Access

    Decoding the spatiotemporal heterogeneity of tumor-associated macrophages

    by Xiangyuan Chu, Yu Tian, Chao Lv

    Tumor-associated macrophages (TAMs) are pivotal in cancer progression, influencing tumor growth, angiogenesis, and immune evasion. This review explores the spatial and temporal heterogeneity of TAMs within the tumor microenvironment (TME), highlighting their diverse subtypes, origins, and functions. Advanced technologies such as single-cell sequencing and spatial multi-omics have elucidated the intricate interactions between TAMs and other TME components, revealing the mechanisms behind their recruitment, polarization, and distribution. Key findings demonstrate that TAMs support tumor vascularization, promote epithelial-mesenchymal transition (EMT), and modulate extracellular matrix (ECM) remodeling, etc., thereby enhancing tumor invasiveness and metastasis. Understanding these complex dynamics offers new therapeutic targets for disrupting TAM-mediated pathways and overcoming drug resistance. This review underscores the potential of targeting TAMs to develop innovative cancer therapies, emphasizing the need for further research into their spatial characteristics and functional roles within the TME.